Similar articles for PMID: 30837272

Year	Number of Results
1992	1
1997	1
1998	1
1999	2
2000	1
2001	2
2005	2
2007	5
2008	2
2010	4
2011	6
2012	8
2013	7
2014	13
2015	5
2016	12
2017	11
2018	7
2019	2
2024	0

1

Grabher BJ. Grabher BJ. J Nucl Med Technol. 2019 Mar;47(1):27-28. doi: 10.2967/jnmt.118.225193. J Nucl Med Technol. 2019. PMID: 30837272 Free article. No abstract available.

2

Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study.

Kupsch AR, Bajaj N, Weiland F, Tartaglione A, Klutmann S, Buitendyk M, Sherwin P, Tate A, Grachev ID. Kupsch AR, et al. J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):620-8. doi: 10.1136/jnnp-2011-301695. Epub 2012 Apr 6. J Neurol Neurosurg Psychiatry. 2012. PMID: 22492213 Clinical Trial.

3

Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.

Graebner AK, Tarsy D, Shih LC, Vanderhorst V, Kulkarni O, Kaplan S, Simon DK. Graebner AK, et al. Neurodegener Dis. 2017;17(1):38-43. doi: 10.1159/000447561. Epub 2016 Sep 10. Neurodegener Dis. 2017. PMID: 27614874

4

Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).

Cummings JL, Fine MJ, Grachev ID, Jarecke CR, Johnson MK, Kuo PH, Schaecher KL, Oberdorf JA, Rezak M, Riley DE, Truong D. Cummings JL, et al. Am J Manag Care. 2014 Mar;20(5 Suppl):S97-109. Am J Manag Care. 2014. PMID: 24773455 Free article.

5

Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.

Tolosa E, Borght TV, Moreno E; DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. Tolosa E, et al. Mov Disord. 2007 Dec;22(16):2346-51. doi: 10.1002/mds.21710. Mov Disord. 2007. PMID: 17914722

6

Amyloid Imaging.

Williams J. Williams J. J Nucl Med Technol. 2018 Dec;46(4):341-342. doi: 10.2967/jnmt.118.222190. J Nucl Med Technol. 2018. PMID: 30518602 Free article. No abstract available.

7

Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan).

Grosset DG, Tatsch K, Oertel WH, Tolosa E, Bajaj N, Kupsch A, O'Brien JT, Seibyl J, Walker Z, Sherwin P, Chen C, Grachev ID. Grosset DG, et al. J Nucl Med. 2014 Aug;55(8):1281-7. doi: 10.2967/jnumed.114.138032. Epub 2014 Jun 19. J Nucl Med. 2014. PMID: 24947061 Free article.

8

Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.

Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Isaacson SH, et al. Expert Rev Neurother. 2017 Mar;17(3):219-225. doi: 10.1080/14737175.2017.1256205. Epub 2016 Nov 23. Expert Rev Neurother. 2017. PMID: 27813429 Review.

9

Pulmonary (V/Q) Imaging.

Thomas KS, Mann A, Williams J. Thomas KS, et al. J Nucl Med Technol. 2018 Jun;46(2):87-88. J Nucl Med Technol. 2018. PMID: 29871994 Free article. No abstract available.

10

Complete and readily reversible blocking of striatal DaTscan binding by methylphenidate.

Cheng G, Morley JF. Cheng G, et al. Clin Nucl Med. 2014 Feb;39(2):211-3. doi: 10.1097/RLU.0000000000000307. Clin Nucl Med. 2014. PMID: 24300364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year